Expect the unexpected.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077156:Gefitinib; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D009102:Multiple Organ Failure / Q000139:chemically induced*; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D011014:Pneumonia / Q000139:chemically induced; D011799:Quinazolines / Q000009:adverse effects
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D011799:Quinazolines; C509303:TGN-1412; D000077156:Gefitinib